Mereo BioPharma Group PLC ADR (MREO) — Free Cash Flow Generation Index
Latest as of September 2023:
1.00x
Mereo BioPharma Group PLC ADR (MREO) has a Free Cash Flow Generation Index of 1.00x as of September 2023. Free cash flow of $2.66 Million represents 1% of operating cash flow ($2.66 Million). See working capital position of Mereo BioPharma Group PLC ADR to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$2.66 Million
USD
Operating Cash Flow
$2.66 Million
USD
Capital Expenditures
$0.00
USD
Annual Free Cash Flow Generation for Mereo BioPharma Group PLC ADR (None–None)
Year-by-year Free Cash Flow Generation Index for Mereo BioPharma Group PLC ADR. For the full company profile including market capitalisation, see MREO market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).